Pharmacologically augmented S-nitrosylated hemoglobin improves recovery from murine subarachnoid hemorrhage.

dc.contributor.author

Sheng, H

dc.contributor.author

Reynolds, JD

dc.contributor.author

Auten, RL

dc.contributor.author

Demchenko, IT

dc.contributor.author

Piantadosi, CA

dc.contributor.author

Stamler, JS

dc.contributor.author

Warner, DS

dc.date.accessioned

2021-06-01T14:17:18Z

dc.date.available

2021-06-01T14:17:18Z

dc.date.issued

2011-02

dc.date.updated

2021-06-01T14:17:17Z

dc.description.abstract

Background and purpose

S-nitrosylated hemoglobin (S-nitrosohemoglobin) has been implicated in the delivery of O(2) to tissues through the regulation of microvascular blood flow. This study tested the hypothesis that enhancement of S-nitrosylated hemoglobin by ethyl nitrite inhalation improves outcome after experimental subarachnoid hemorrhage (SAH).

Methods

A preliminary dosing study identified 20 ppm ethyl nitrite as a concentration that produced a 4-fold increase in S-nitrosylated hemoglobin concentration with no increase in methemoglobin. Mice were subjected to endovascular perforation of the right anterior cerebral artery and were treated with 20 ppm ethyl nitrite in air, or air alone for 72 hours, after which neurologic function, cerebral vessel diameter, brain water content, cortical tissue Po(2), and parenchymal red blood cell flow velocity were measured.

Results

At 72 hours after hemorrhage, air- and ethyl nitrite-exposed mice had similarly sized blood clots. Ethyl nitrite improved neurologic score and rotarod performance; abated SAH-induced constrictions in the ipsilateral anterior, middle cerebral, and internal carotid arteries; and prevented an increase in ipsilateral brain water content. Ethyl nitrite inhalation increased red blood cell flow velocity and cortical tissue Po(2) in the ipsilateral cortex with no effect on systemic blood pressure.

Conclusions

Targeted S-nitrosylation of hemoglobin improved outcome parameters, including vessel diameter, tissue blood flow, cortical tissue Po(2), and neurologic function in a murine SAH model. Augmenting endogenous Po(2)-dependent delivery of NO bioactivity to selectively dilate the compromised cerebral vasculature has significant clinical potential in the treatment of SAH.
dc.identifier

STROKEAHA.110.600569

dc.identifier.issn

0039-2499

dc.identifier.issn

1524-4628

dc.identifier.uri

https://hdl.handle.net/10161/23293

dc.language

eng

dc.publisher

Ovid Technologies (Wolters Kluwer Health)

dc.relation.ispartof

Stroke

dc.relation.isversionof

10.1161/strokeaha.110.600569

dc.subject

Animals

dc.subject

Mice, Inbred C57BL

dc.subject

Mice

dc.subject

Subarachnoid Hemorrhage

dc.subject

Nitrites

dc.subject

Hemoglobins

dc.subject

Adjuvants, Pharmaceutic

dc.subject

Administration, Inhalation

dc.subject

Recovery of Function

dc.subject

Drug Synergism

dc.subject

Male

dc.title

Pharmacologically augmented S-nitrosylated hemoglobin improves recovery from murine subarachnoid hemorrhage.

dc.type

Journal article

duke.contributor.orcid

Sheng, H|0000-0002-4325-2940

pubs.begin-page

471

pubs.end-page

476

pubs.issue

2

pubs.organisational-group

School of Medicine

pubs.organisational-group

Anesthesiology

pubs.organisational-group

Duke

pubs.organisational-group

Clinical Science Departments

pubs.organisational-group

Neurobiology

pubs.organisational-group

Duke Institute for Brain Sciences

pubs.organisational-group

Surgery

pubs.organisational-group

Anesthesiology, Neuroanesthesia

pubs.organisational-group

Basic Science Departments

pubs.organisational-group

University Institutes and Centers

pubs.organisational-group

Institutes and Provost's Academic Units

pubs.organisational-group

Medicine, Pulmonary, Allergy, and Critical Care Medicine

pubs.organisational-group

Medicine

pubs.organisational-group

Pathology

pubs.organisational-group

Faculty

pubs.publication-status

Published

pubs.volume

42

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Sheng 2011a.pdf
Size:
956.06 KB
Format:
Adobe Portable Document Format